Health & Biotech
Stories by Tim Boreham
Mining
Inferred: What the miner said at Diggers and Dealers. Measured: What the miner meant
Health & Biotech
Dr Boreham’s Crucible: Are palatable poo tests in Australia about to finally hit their Rhythm?
Experts
CRITERION: Costs are rising but gold is hanging on to its lustre
Tech
CRITERION: 3 tasty stocks the tech recovery forgot
Health & Biotech
Dr Boreham’s Crucible: Is serial shopper Trajan Group a buy?
News
CRITERION: It’s a small cap smorgasboard with takeover targets on the table
Experts
CRITERION: Credit where it’s due – these ASX collectors are knocking on the door
Health & Biotech
Dr Boreham’s Crucible: Will the FDA bend the knee after Paradigm’s Phase III tests?
Experts
CRITERION: Taking a punt on gambling stocks? It’s not as black and red as it used to be
News
CRITERION: Fear a falling market? Maybe an ‘anti-market’ ETF is the hedge you’re looking for
Health & Biotech